Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. 1994

A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
Department of Pediatrics, University of Colorado School of Medicine, Denver.

A 10-day-old infant with stridor was found to have herpes simplex virus type 2 infection of the larynx. The infant's poor clinical response to both acyclovir and foscarnet prompted extensive clinical and virologic evaluations, which revealed acyclovir-resistant herpes simplex virus.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007818 Laryngeal Diseases Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing. Laryngeal Perichondritis,Larynx Diseases,Disease, Laryngeal,Disease, Larynx,Diseases, Laryngeal,Diseases, Larynx,Laryngeal Disease,Laryngeal Perichondritides,Larynx Disease,Perichondritides, Laryngeal,Perichondritis, Laryngeal
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D017245 Foscarnet An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. Phosphonoformate,Phosphonoformic Acid,Foscarnet Barium (2:3) Salt,Foscarnet Calcium (2:3) Salt,Foscarnet Disodium Salt,Foscarnet Magnesium (2:3) Salt,Foscarnet Manganese (2+) (2:3) Salt,Foscarnet Sodium,Foscarnet Sodium Hexahydrate,Foscarnet Trilithium Salt,Foscarnet Tripotassium Salt,Foscarnet Trisodium Salt,Foscavir,Trisodium Phosphonoformate
D018258 Herpesvirus 2, Human A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact. HSV-2,Herpes Simplex Virus 2,Human Herpesvirus 2,HHV-2,Herpes Simplex Virus Type 2,Herpesvirus 2 (alpha), Human

Related Publications

A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
August 1995, The Journal of infectious diseases,
A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
January 1982, Pediatric infectious disease,
A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
August 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
September 1984, Ugeskrift for laeger,
A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
September 1982, The New England journal of medicine,
A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
September 1990, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
April 2003, Dermatologic clinics,
A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
December 1987, Lancet (London, England),
A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
December 2007, Pathologie-biologie,
A C Nyquist, and H A Rotbart, and M Cotton, and C Robinson, and A Weinberg, and A R Hayward, and R L Berens, and M J Levin
November 1987, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!